bridg ep detail
bridg lot move part conf call provid
addit color relat guidanc point increas headwind
measur appropri conservat need view given
underli headwind specif management indic ep growth would see
headwind pt bonu accrual normal vs reduct
addit wba tax rate equat
ep headwind also expect rx reimburs larger headwind
previou year medicaid contract renew prior switch
yr renew cycl offset item would share repurchas contribut
pt ep growth core oper improv seemingli
includ stepped-up digit invest collect lead compani flat
ep expect headwind mechan comp invest
natur wba comment regard increas us rx reimburs headwind
somewhat concern view may abl mitig
histor off-set gener tshe key also hope make
price pressur greater rx volum model us rx growth
vs rx growth partial boost asset purchas
tweak ep togeth tweak ep slightli lower
largest chang model larg relat
retail pharmaci us busi account elev level
reimburs headwind expect retail us gross margin
vs bp expect total compani ebit declin
y/i basi retail us ebit declin given elev level reimburs
headwind addit invest spend see pg color
believ wba ep guid achiev plenti us pharmaci hurdl
overcom and/or flex compani overal expens line maintain ew
rate pt base new ep
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight walgreen continu move
reinvent busi reimburs
continu headwind compani cost
cut strategi much
reflect stock valuat
upsid case see sign improv
reimburs better traction
compani partnership lead multipl
pressur minim improv compani
oper structur lead multipl contract
note quarter
beyond guidanc management provid addit inform regard
incom quarter pharmaci gross margin declin bp reflect
bp neg impact specialti continu reimburs pressur retail
portion busi saw gross margin improv bp comp sale
exclud tobacco management de-emphasize recent year
compani announc addit partnership alongsid earn compani
announc jenni craig would open jenni craig variou walgreen locat
separ compani also announc walgreen would transit seven
exist walgreen healthcar clinic trihealth alongsid announc management
indic current relationship go well specif fedex
partnership capac labcorp relationship income-posit
manag indic expect see continu consolid pharmaci
space move forward compani good pipelin pharmaci
consolid compani cost manag program made variou
corpor offic reduct across variou segment continu work
system compani expect see mln increas expens
mln higher contribut expect capit mln mln
higher
 epsflat y/i /- growth yr/yrflatadjust tax mlnbalanc ep across halvesrx growth higher flat eps- adj effect tax net share op barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
